Cyclooxygenase-2 Inhibition suppresses ?vß6 integrin-dependent oral squamous carcinoma invasion
Worldwide oral squamous cell carcinoma (OSCC) represents about 5.5% of all malignancies, with ~30,000 new cases each year in the United States. The integrin ?vß6 and the enzyme cyclooxygenase-2 (COX-2) are implicated in OSCC progression and have been suggested as possible therapeutic targets. Each p...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2006-11-15.
|
| Subjects: | |
| Online Access: | Get fulltext |